Poseida Therapeutics, Inc. License Agreements
10 Contracts & Agreements
- Amended and Restated License Agreement, by and between the Registrant and Helmholtz-Zentrum MnchenDeutsches Forschungszentrum fr Gesundheit und Umwelt GmbH, executed as of March... (Filed With SEC on May 11, 2021)
- License Agreement, by and between the Registrant and Genus Oncology, LLC, effective October 24, 2019 (Filed With SEC on June 19, 2020)
- License Agreement, by and between the Registrant and Helmholtz-Zentrum MnchenDeutsches Forschungszentrum fr Gesundheit und Umwelt GmbH, effective May 20, 2016 (Filed With SEC on June 19, 2020)
- Commercial License Agreement, by and between the Registrant and TeneoBio, Inc., effective August 3, 2018 (Filed With SEC on June 19, 2020)
- Commercial License Agreement, by and between the Registrant and TeneoBio, Inc., effective April 27, 2017 (Filed With SEC on June 19, 2020)
- License Agreement, by and between the Registrant and Janssen Biotech, Inc., effective August 3, 2015 (Filed With SEC on June 19, 2020)
- License Agreement, by and between the Registrant and Helmholtz-Zentrum MnchenDeutsches Forschungszentrum fr Gesundheit und Umwelt GmbH, effective May 20, 2016 (Filed With SEC on January 4, 2019)
- Commercial License Agreement, by and between the Registrant and TeneoBio, Inc., effective August 3, 2018 (Filed With SEC on January 4, 2019)
- Commercial License Agreement, by and between the Registrant and TeneoBio, Inc., effective April 27, 2017 (Filed With SEC on January 4, 2019)
- License Agreement, by and between the Registrant and Janssen Biotech, Inc., effective August 3, 2015 (Filed With SEC on January 4, 2019)
